Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

Whether the Federal Circuit applied the correct standard for evaluating the patent claims at issue in this pharmaceutical dispute.

The Court will consider a pharmaceutical patent dispute about the scope of patent protections for branded drugs and the ability of generic manufacturers to enter the market.